Pharmaceutical manufacturing

FILE - In this June 6, 2019, file photo specialist John Parisi, left, works with traders on the floor of the New York Stock Exchange. The U.S. stock market opens at 9:30 a.m. EDT on Friday, July 12. (AP Photo/Richard Drew, File)
July 12, 2019 - 4:30 pm
NEW YORK (AP) — The major U.S. stock indexes closed at record highs on Friday, with the S&P 500 ending above 3,000 for the first time. The market was driven higher by technology, consumer discretionary and industrial company stocks, which more than offset the drop in drugmakers. Investors...
Read More
President Donald Trump speaks about kidney health at the Ronald Reagan Building and International Trade Center, accompanied by Health and Human Services Secretary Alex Azar, left, Wednesday, July 10, 2019, in Washington. (AP Photo/Alex Brandon)
July 11, 2019 - 6:08 pm
WASHINGTON (AP) — After two setbacks this week, President Donald Trump is now focusing his drive to curb drug costs on congressional efforts aimed at helping people on Medicare and younger generations covered by workplace plans. The White House on Thursday yanked its own regulation to ease the...
Read More
FILE - In this Oct. 25, 2018, file photo, President Donald Trump talks about drug prices during a visit to the Department of Health and Human Services in Washington. A federal judge Monday, July 8, 2019, blocked a major White House initiative on prescription drug costs, saying the Trump administration lacked the legal authority to require drugmakers to disclose their prices in TV ads. (AP Photo/Susan Walsh, File)
July 08, 2019 - 10:51 pm
WASHINGTON (AP) — A federal judge Monday blocked a major White House initiative on prescription drug costs, saying the Trump administration lacked the legal authority to require drugmakers to disclose their prices in TV ads. The narrow ruling by U.S. District Judge Amit Mehta in Washington, D.C.,...
Read More
President Donald Trump talks to reporters on the South Lawn of the White House before departing for his Bedminster, N.J. golf club, Friday, July 5, 2019, in Washington. (AP Photo/Evan Vucci)
July 05, 2019 - 1:04 pm
WASHINGTON (AP) — President Donald Trump is promising an executive order that he says is intended to enable the U.S. government to pay lower prices for prescription drugs. Trump says his administration soon would announce a "favored-nations clause," where the amount paid by the government for a...
Read More
July 01, 2019 - 1:47 pm
FRANKFORT, Ky. (AP) — More than two dozen Catholic school students and their parents have lost their initial appeal in challenging a Kentucky health department's efforts to control a chickenpox outbreak they claim infringed on their religious beliefs. A three-judge panel of the Kentucky Court of...
Read More
In this June 5, 2009, photo a woman has Botox injected at Reveal in Arlington, Va. AbbVie is buying Botox maker Allergan in a cash-and-stock deal the drugmakers value at around $63 billion. The maker of the blockbuster immune disorder treatment Humira said Tuesday, June 25, 2019, that it will pay $120.30 in cash and a portion of AbbVie stock for each Allergan share. (AP Photo/Jacquelyn Martin, File)
June 25, 2019 - 2:39 pm
Facing competition for the world's top-selling drug, AbbVie is jumping on this year's pharmaceutical merger bandwagon with a $63 billion bid for Botox maker Allergan that's meant to spur future growth. Specialty drugmaker AbbVie said Tuesday that adding Allergan's aesthetics products and eye care...
Read More
FILE - This Dec. 4, 2017, file photo shows the Pfizer company logo at the company's headquarters in New York. Pfizer is buying the cancer treatment company Array BioPharma in a deal worth $11.4 billion. Array has a combination therapy for BRAF-mutant metastatic melanoma, along with a pipeline of targeted cancer medicines in development and a portfolio of other medicines that are expected to generate significant royalties over time. (AP Photo/Richard Drewm Fuke, File)
June 17, 2019 - 8:28 am
NEW YORK (AP) — Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing positive clinical trial results earlier this spring. Pfizer said Monday it will pay $48 per share in cash for Array,...
Read More
June 14, 2019 - 5:38 am
BERLIN (AP) — German chemical and pharmaceutical company Bayer says it plans to invest some 5 billion euros ($5.6 billion) over the next decade in developing "additional methods to combat weeds." Friday's announcement came as Bayer is engaged in legal battles in the U.S. in which plaintiffs claim...
Read More
This March 26, 2018 photo provided by Ashley Atwater shows her mother, Sally Atwater, outside her home in the Georgetown area of Washington, a few days after leaving the hospital. Atwater's doctor spent two months on calls, messages and dozens of pages of forms to get her an experimental drug he thinks can fight the lung cancer that has spread to her brain and spine. (Courtesy Ashley Atwater via AP)
June 03, 2019 - 9:59 am
CHICAGO (AP) — Sally Atwater's doctor spent two months on calls, messages and paperwork to get her an experimental drug he thinks can fight the lung cancer that has spread to her brain and spine. Nancy Goodman begged eight companies to let her young son try experimental medicines for a brain tumor...
Read More
May 29, 2019 - 11:24 am
PHILADELPHIA (AP) — The U.S. attorney's office in Philadelphia says a pharmaceutical company is agreeing to pay $3.5 million to settle claims it paid kickbacks to dermatology providers to encourage them to prescribe their drugs. U.S. Attorney William McSwain said Wednesday the matter involved...
Read More

Pages